Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
abbreviated, adoptEITF, adoptFSP, ARB, arbitrator, AST, attestation, AU, auditor, Bausch, blockbuster, bore, Burlingame, byRule, carryforward, Christine, cliff, confidence, coupled, coupon, coursework, cure, database, deleted, delisted, delisting, destruction, doubling, EITFIssue, enable, Enbrel, EPOGEN, Ernst, extinguishment, FASNo, FDCA, fifteen, forfeited, FSP, FSPNo, fundamental, Grandfathered, hierarchy, illustrative, lay, likelihood, Lomb, Nephrology, network, Noncontrolling, nonfinancial, nongovernmental, Ocampo, ofEITF, ofFSP, Oncology, OrbiMed, Payoff, premium, Prilosec, privilege, prohibit, ProQuest, regain, resale, Seattle, slowdown, STAR, strongest, sublet, Subscription, taxation, theft, thisForm, tier, transparency, Treasurer, uninsured, unutilized, Vivo, worth, wrote, Young
Removed:
abandoned, accurately, adjacent, administer, agency, AMEX, assume, attributable, AVN, building, cholesterol, commencing, comparing, conclusion, consultant, contingency, continuation, cytokine, decided, deducting, deficit, desirable, devoted, discovered, disruptive, donor, education, effected, elimination, expansion, forma, founder, FTE, handling, headcount, hiring, hourly, Humane, implementation, indicted, influenced, initiation, Institute, invention, label, leading, long, measurable, Medarex, medimmune, mice, molecule, monthly, multicenter, natural, open, Paul, pertain, pharmacological, pipeline, pool, predict, principle, pro, prophylactic, published, ratably, RCT, recently, recombinant, reducing, requested, resigned, retain, retrospective, reverse, Road, scientific, selected, selective, simultaneously, source, split, symbol, transport, twenty, unaudited, unearned, unionized, unique, unpredictable, uphold, wholly, Yakatan
Filing tables
Filing exhibits
Related press release
AVNR similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)
THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)
In connection with the accompanying Annual Report of AVANIR Pharmaceuticals (the “Company”) on Form 10-K for the fiscal year ended September 30, 2008 (the “Report”), I, Keith A Katkin, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: December 17, 2008 | /s/ Keith A. Katkin | |||
| President and Chief Executive Officer | ||||
| [Principal Executive Officer] |